Akebia Therapeutics Inc AKBA:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/17/24 EDT
1.15UNCH (UNCH)
Volume
37,596,200
Close
1.15quote price arrow up+0.01 (+0.88%)
Volume
2,392,797
52 week range
0.78 - 2.48
Loading...
  • Open1.13
  • Day High1.18
  • Day Low1.12
  • Prev Close1.14
  • 52 Week High2.48
  • 52 Week High Date03/28/24
  • 52 Week Low0.78
  • 52 Week Low Date10/26/23

Key Stats

  • Market Cap241.036M
  • Shares Out209.60M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.79
  • YTD % Change-7.26

KEY STATS

  • Open1.13
  • Day High1.18
  • Day Low1.12
  • Prev Close1.14
  • 52 Week High2.48
  • 52 Week High Date03/28/24
  • 52 Week Low0.78
  • 52 Week Low Date10/26/23
  • Market Cap241.036M
  • Shares Out209.60M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.79
  • YTD % Change-7.26

RATIOS/PROFITABILITY

  • EPS (TTM)-0.22
  • P/E (TTM)-5.20
  • Fwd P/E (NTM)-3.97
  • EBITDA (TTM)2.733M
  • ROE (TTM)-558.59%
  • Revenue (TTM)187.225M
  • Gross Margin (TTM)82.75%
  • Net Margin (TTM)-22.98%
  • Debt To Equity (MRQ)-110.59%

EVENTS

  • Earnings Date08/23/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Akebia Therapeutics Inc

 

Profile

MORE
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company. The Company is focused on developing and commercializing therapeutics. The Company’s portfolio and hypoxia-inducible factor (HIF)-based pipeline includes Auryxia (ferric citrate), Vafseo (vadadustat), AKB-9090 and AKB-10108. Auryxia (ferric citrate) is an orally administered medicine approved and marketed in the United States for two indications: the control of serum phosphorus levels in adult patients...
Adrian Adams
Independent Chairman of the Board
John Butler
President, Chief Executive Officer, Interim Principal Financial Officer, Director
Michel Dahan
Chief Operating Officer, Senior Vice President
Richard Malabre
Chief Accounting Officer
Address
245 First Street
Cambridge, MA
02142
United States

Top Peers

SYMBOLLASTCHG%CHG
XERS
Xeris Biopharma Holdings Inc
1.98-0.04-1.98%
AGEN
Agenus Inc
10.86+0.36+3.43%
PBYI
Puma Biotechnology Inc
4.09-0.32-7.14%
FGEN
FibroGen Inc
1.20-0.04-3.23%
STRO
Sutro Biopharma Inc
4.01-0.14-3.37%